Lynch & Associates IN trimmed its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 44,202 shares of the pharmacy operator’s stock after selling 1,625 shares during the period. Lynch & Associates IN’s holdings in Walgreens Boots Alliance were worth $3,210,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Franklin Resources Inc. grew its position in shares of Walgreens Boots Alliance by 24.7% during the second quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after acquiring an additional 3,662,302 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of Walgreens Boots Alliance by 471.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after acquiring an additional 2,718,800 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Walgreens Boots Alliance by 2.8% during the second quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after acquiring an additional 1,926,108 shares during the last quarter. Glenview Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the second quarter worth about $136,875,000. Finally, Harding Loevner LP grew its position in shares of Walgreens Boots Alliance by 85.3% during the third quarter. Harding Loevner LP now owns 2,844,207 shares of the pharmacy operator’s stock worth $115,725,000 after acquiring an additional 1,309,179 shares during the last quarter. 61.20% of the stock is currently owned by institutional investors.

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $76.03 on Wednesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00. The company has a market cap of $75,300.00, a PE ratio of 21.00, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. During the same period in the prior year, the firm earned $1.10 earnings per share. The business’s quarterly revenue was up 7.9% on a year-over-year basis. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.7 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its board has initiated a share repurchase program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

A number of equities analysts recently issued reports on WBA shares. Needham & Company LLC reiterated a “buy” rating and issued a $88.00 target price (up previously from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Loop Capital set a $90.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. Robert W. Baird reiterated an “outperform” rating and issued a $80.00 target price (down previously from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Royal Bank of Canada started coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 target price for the company. Nine investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $86.20.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/01/17/lynch-associates-in-reduces-holdings-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related stocks with our FREE daily email newsletter.